Literature DB >> 23904505

Project data sphere to make cancer clinical trial data publicly available.

Karyn Hede.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23904505     DOI: 10.1093/jnci/djt232

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  14 in total

1.  The project data sphere initiative: accelerating cancer research by sharing data.

Authors:  Angela K Green; Katherine E Reeder-Hayes; Robert W Corty; Ethan Basch; Mathew I Milowsky; Stacie B Dusetzina; Antonia V Bennett; William A Wood
Journal:  Oncologist       Date:  2015-04-15

2.  Disparities in castration-resistant prostate cancer trials.

Authors:  Daniel E Spratt; Joseph R Osborne
Journal:  J Clin Oncol       Date:  2015-02-17       Impact factor: 44.544

3.  DO CANCER CLINICAL TRIAL POPULATIONS TRULY REPRESENT CANCER PATIENTS? A COMPARISON OF OPEN CLINICAL TRIALS TO THE CANCER GENOME ATLAS.

Authors:  Nophar Geifman; Atul J Butte
Journal:  Pac Symp Biocomput       Date:  2016

4.  Big Data in Pharmaceutical R&D: Creating a Sustainable R&D Engine.

Authors:  Peter Tormay
Journal:  Pharmaceut Med       Date:  2015

Review 5.  Views of Ethical Best Practices in Sharing Individual-Level Data From Medical and Public Health Research: A Systematic Scoping Review.

Authors:  Susan Bull; Nia Roberts; Michael Parker
Journal:  J Empir Res Hum Res Ethics       Date:  2015-07       Impact factor: 1.742

6.  Opening clinical trial data: are the voluntary data-sharing portals enough?

Authors:  Nophar Geifman; Jennifer Bollyky; Sanchita Bhattacharya; Atul J Butte
Journal:  BMC Med       Date:  2015-11-11       Impact factor: 8.775

7.  A patient-level data meta-analysis of standard-of-care treatments from eight prostate cancer clinical trials.

Authors:  N Geifman; A J Butte
Journal:  Sci Data       Date:  2016-05-10       Impact factor: 6.444

8.  UK publicly funded Clinical Trials Units supported a controlled access approach to share individual participant data but highlighted concerns.

Authors:  Carolyn Hopkins; Matthew Sydes; Gordon Murray; Kerry Woolfall; Mike Clarke; Paula Williamson; Catrin Tudur Smith
Journal:  J Clin Epidemiol       Date:  2015-07-11       Impact factor: 6.437

9.  Anonymising and sharing individual patient data.

Authors:  Khaled El Emam; Sam Rodgers; Bradley Malin
Journal:  BMJ       Date:  2015-03-20

10.  Antibacterial Use Is Associated with an Increased Risk of Hematologic and Gastrointestinal Adverse Events in Patients Treated with Gemcitabine for Stage IV Pancreatic Cancer.

Authors:  Robert W Corty; Benjamin W Langworthy; Jason P Fine; John B Buse; Hanna K Sanoff; Jennifer L Lund
Journal:  Oncologist       Date:  2020-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.